609 related articles for article (PubMed ID: 28494905)
41. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
Bash LD; Turzhitsky V; Black W; Urman RD
Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
[TBL] [Abstract][Full Text] [Related]
42. Sugammadex facilitates early recovery after surgery even in the absence of neuromuscular monitoring in patients undergoing laryngeal microsurgery: a single-center retrospective study.
Park ES; Lim BG; Lee WJ; Lee IO
BMC Anesthesiol; 2016 Aug; 16(1):48. PubMed ID: 27484887
[TBL] [Abstract][Full Text] [Related]
43. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
[TBL] [Abstract][Full Text] [Related]
44. Sugammadex
Chhabra R; Gupta R; Gupta LK
Curr Drug Saf; 2024; 19(1):33-43. PubMed ID: 36861797
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
[TBL] [Abstract][Full Text] [Related]
46. Use of Sugammadex in Patients With Obesity: A Pooled Analysis.
Monk TG; Rietbergen H; Woo T; Fennema H
Am J Ther; 2017; 24(5):e507-e516. PubMed ID: 26398716
[TBL] [Abstract][Full Text] [Related]
47. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
Dahaba AA; Bornemann H; Hopfgartner E; Ohran M; Kocher K; Liebmann M; Wilfinger G; Metzler H
Br J Anaesth; 2012 Apr; 108(4):602-6. PubMed ID: 22315331
[TBL] [Abstract][Full Text] [Related]
48. Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy.
Aouad MT; Alfahel WS; Kaddoum RN; Siddik-Sayyid SM
BMC Anesthesiol; 2017 Apr; 17(1):57. PubMed ID: 28399799
[TBL] [Abstract][Full Text] [Related]
49. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
Gaszynski T; Szewczyk T; Gaszynski W
Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861
[TBL] [Abstract][Full Text] [Related]
50. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
[TBL] [Abstract][Full Text] [Related]
51. Association between reversal agents (sugammadex vs. neostigmine) for neuromuscular block and postoperative pulmonary complications: A retrospective analysis.
Ren A; Fan M; Gu Z; Liang X; Xu L; Liu C; Wang D; Chang H; Zhu M
Br J Clin Pharmacol; 2024 Jul; 90(7):1667-1676. PubMed ID: 38583490
[TBL] [Abstract][Full Text] [Related]
52. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation.
Paton F; Paulden M; Chambers D; Heirs M; Duffy S; Hunter JM; Sculpher M; Woolacott N
Br J Anaesth; 2010 Nov; 105(5):558-67. PubMed ID: 20935005
[TBL] [Abstract][Full Text] [Related]
53. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
Meistelman C; Donati F
Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
[TBL] [Abstract][Full Text] [Related]
54. Effects of dexamethasone on sugammadex reversal times of rocuronium: a systematic review protocol.
Held CR; Sullivan MD
JBI Database System Rev Implement Rep; 2017 Jun; 15(6):1543-1551. PubMed ID: 28628514
[TBL] [Abstract][Full Text] [Related]
55. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
Voss T; Wang A; DeAngelis M; Speek M; Saldien V; Hammer GB; Wrishko R; Herring WJ
Paediatr Anaesth; 2022 Mar; 32(3):436-445. PubMed ID: 34878707
[TBL] [Abstract][Full Text] [Related]
56. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
[TBL] [Abstract][Full Text] [Related]
57. Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure.
Choi ES; Oh AY; Koo BW; Hwang JW; Han JW; Seo KS; Ahn SH; Jeong WJ
Anaesthesia; 2017 Oct; 72(10):1185-1190. PubMed ID: 28493510
[TBL] [Abstract][Full Text] [Related]
58. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
de Boer HD; Carlos RV; Brull SJ
BMC Anesthesiol; 2018 Nov; 18(1):159. PubMed ID: 30400850
[TBL] [Abstract][Full Text] [Related]
59. Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular Block in Patients Having Catheter-Based Neurointerventional Procedures: A Randomized Trial.
Farag E; Rivas E; Bravo M; Hussain S; Argalious M; Khanna S; Seif J; Pu X; Mao G; Bain M; Elgabaly M; Esa WAS; Sessler DI
Anesth Analg; 2021 Jun; 132(6):1666-1676. PubMed ID: 34032663
[TBL] [Abstract][Full Text] [Related]
60. A novel approach to reversal of neuromuscular blockade.
Della Rocca G; Pompei L
Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
